date: 2019-05-03T10:41:13Z
pdf:PDFVersion: 1.5
pdf:docinfo:title: Spectroscopic Characterization and Cytotoxicity Assessment towards Human Colon Cancer Cell Lines of Acylated Cycloartane Glycosides from Astragalus boeticus L.
xmp:CreatorTool: LaTeX with hyperref package
access_permission:can_print_degraded: true
subject: In several European countries, especially in Sweden, the seeds of the species Astragalus boeticus L. were widely used as coffee substitutes during the 19th century. Nonetheless, data regarding the phytochemistry and the pharmacological properties of this species are currently extremely limited. Conversely, other species belonging to the Astragalus genus have already been extensively investigated, as they were used for millennia for treating various diseases, including cancer. The current work was addressed to characterize cycloartane glycosides from A. boeticus, and to evaluate their cytotoxicity towards human colorectal cancer (CRC) cell lines. The isolation of the metabolites was performed by using different chromatographic techniques, while their chemical structures were elucidated by nuclear magnetic resonance (NMR) (1D and 2D techniques) and electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry. The cytotoxic assessment was performed in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays in Caco-2, HT-29 and HCT-116 CRC cells. As a result, the targeted phytochemical study of A. boeticus enabled the isolation of three new cycloartane glycosides, 6-O-acetyl-3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (1), 3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (2), 6-O-acetyl-25-O?d-glucopyranosyl- 3-O?d-xylopyranosylcycloastragenol (3) along with two known compounds, 6-O-acetyl-3-O?d-xylopyranosylcycloastragenol (4) and 3-O?d-xylopyranosylcycloastragenol (5). Importantly, this work demonstrated that the acetylated cycloartane glycosides 1 and 4 might preferentially inhibit cell growth in the CRC cell model resistant to epidermal growth factor receptor (EGFR) inhibitors.
dc:format: application/pdf; version=1.5
pdf:docinfo:creator_tool: LaTeX with hyperref package
access_permission:fill_in_form: true
pdf:encrypted: false
dc:title: Spectroscopic Characterization and Cytotoxicity Assessment towards Human Colon Cancer Cell Lines of Acylated Cycloartane Glycosides from Astragalus boeticus L.
modified: 2019-05-03T10:41:13Z
cp:subject: In several European countries, especially in Sweden, the seeds of the species Astragalus boeticus L. were widely used as coffee substitutes during the 19th century. Nonetheless, data regarding the phytochemistry and the pharmacological properties of this species are currently extremely limited. Conversely, other species belonging to the Astragalus genus have already been extensively investigated, as they were used for millennia for treating various diseases, including cancer. The current work was addressed to characterize cycloartane glycosides from A. boeticus, and to evaluate their cytotoxicity towards human colorectal cancer (CRC) cell lines. The isolation of the metabolites was performed by using different chromatographic techniques, while their chemical structures were elucidated by nuclear magnetic resonance (NMR) (1D and 2D techniques) and electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry. The cytotoxic assessment was performed in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays in Caco-2, HT-29 and HCT-116 CRC cells. As a result, the targeted phytochemical study of A. boeticus enabled the isolation of three new cycloartane glycosides, 6-O-acetyl-3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (1), 3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (2), 6-O-acetyl-25-O?d-glucopyranosyl- 3-O?d-xylopyranosylcycloastragenol (3) along with two known compounds, 6-O-acetyl-3-O?d-xylopyranosylcycloastragenol (4) and 3-O?d-xylopyranosylcycloastragenol (5). Importantly, this work demonstrated that the acetylated cycloartane glycosides 1 and 4 might preferentially inhibit cell growth in the CRC cell model resistant to epidermal growth factor receptor (EGFR) inhibitors.
pdf:docinfo:subject: In several European countries, especially in Sweden, the seeds of the species Astragalus boeticus L. were widely used as coffee substitutes during the 19th century. Nonetheless, data regarding the phytochemistry and the pharmacological properties of this species are currently extremely limited. Conversely, other species belonging to the Astragalus genus have already been extensively investigated, as they were used for millennia for treating various diseases, including cancer. The current work was addressed to characterize cycloartane glycosides from A. boeticus, and to evaluate their cytotoxicity towards human colorectal cancer (CRC) cell lines. The isolation of the metabolites was performed by using different chromatographic techniques, while their chemical structures were elucidated by nuclear magnetic resonance (NMR) (1D and 2D techniques) and electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry. The cytotoxic assessment was performed in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays in Caco-2, HT-29 and HCT-116 CRC cells. As a result, the targeted phytochemical study of A. boeticus enabled the isolation of three new cycloartane glycosides, 6-O-acetyl-3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (1), 3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (2), 6-O-acetyl-25-O?d-glucopyranosyl- 3-O?d-xylopyranosylcycloastragenol (3) along with two known compounds, 6-O-acetyl-3-O?d-xylopyranosylcycloastragenol (4) and 3-O?d-xylopyranosylcycloastragenol (5). Importantly, this work demonstrated that the acetylated cycloartane glycosides 1 and 4 might preferentially inhibit cell growth in the CRC cell model resistant to epidermal growth factor receptor (EGFR) inhibitors.
pdf:docinfo:creator: Vittoria Graziani, Assunta Esposito, Monica Scognamiglio, Angela Chambery, Rosita Russo, Fortunato Ciardiello, Teresa Troiani, Nicoletta Potenza, Antonio Fiorentino and Brigida D?Abrosca
PTEX.Fullbanner: This is pdfTeX, Version 3.14159265-2.6-1.40.17 (TeX Live 2016/W32TeX) kpathsea version 6.2.2
meta:author: Vittoria Graziani, Assunta Esposito, Monica Scognamiglio, Angela Chambery, Rosita Russo, Fortunato Ciardiello, Teresa Troiani, Nicoletta Potenza, Antonio Fiorentino and Brigida D?Abrosca
trapped: False
meta:creation-date: 2019-05-03T08:29:02Z
created: 2019-05-03T08:29:02Z
access_permission:extract_for_accessibility: true
Creation-Date: 2019-05-03T08:29:02Z
Author: Vittoria Graziani, Assunta Esposito, Monica Scognamiglio, Angela Chambery, Rosita Russo, Fortunato Ciardiello, Teresa Troiani, Nicoletta Potenza, Antonio Fiorentino and Brigida D?Abrosca
producer: pdfTeX-1.40.17
pdf:docinfo:producer: pdfTeX-1.40.17
pdf:unmappedUnicodeCharsPerPage: 17
dc:description: In several European countries, especially in Sweden, the seeds of the species Astragalus boeticus L. were widely used as coffee substitutes during the 19th century. Nonetheless, data regarding the phytochemistry and the pharmacological properties of this species are currently extremely limited. Conversely, other species belonging to the Astragalus genus have already been extensively investigated, as they were used for millennia for treating various diseases, including cancer. The current work was addressed to characterize cycloartane glycosides from A. boeticus, and to evaluate their cytotoxicity towards human colorectal cancer (CRC) cell lines. The isolation of the metabolites was performed by using different chromatographic techniques, while their chemical structures were elucidated by nuclear magnetic resonance (NMR) (1D and 2D techniques) and electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry. The cytotoxic assessment was performed in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays in Caco-2, HT-29 and HCT-116 CRC cells. As a result, the targeted phytochemical study of A. boeticus enabled the isolation of three new cycloartane glycosides, 6-O-acetyl-3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (1), 3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (2), 6-O-acetyl-25-O?d-glucopyranosyl- 3-O?d-xylopyranosylcycloastragenol (3) along with two known compounds, 6-O-acetyl-3-O?d-xylopyranosylcycloastragenol (4) and 3-O?d-xylopyranosylcycloastragenol (5). Importantly, this work demonstrated that the acetylated cycloartane glycosides 1 and 4 might preferentially inhibit cell growth in the CRC cell model resistant to epidermal growth factor receptor (EGFR) inhibitors.
Keywords: Astragalus boeticus L.; spectroscopic analysis; cytotoxic activity; human colon cancer cell lines; acetylated astragalosides; Fabaceae
access_permission:modify_annotations: true
dc:creator: Vittoria Graziani, Assunta Esposito, Monica Scognamiglio, Angela Chambery, Rosita Russo, Fortunato Ciardiello, Teresa Troiani, Nicoletta Potenza, Antonio Fiorentino and Brigida D?Abrosca
description: In several European countries, especially in Sweden, the seeds of the species Astragalus boeticus L. were widely used as coffee substitutes during the 19th century. Nonetheless, data regarding the phytochemistry and the pharmacological properties of this species are currently extremely limited. Conversely, other species belonging to the Astragalus genus have already been extensively investigated, as they were used for millennia for treating various diseases, including cancer. The current work was addressed to characterize cycloartane glycosides from A. boeticus, and to evaluate their cytotoxicity towards human colorectal cancer (CRC) cell lines. The isolation of the metabolites was performed by using different chromatographic techniques, while their chemical structures were elucidated by nuclear magnetic resonance (NMR) (1D and 2D techniques) and electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry. The cytotoxic assessment was performed in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays in Caco-2, HT-29 and HCT-116 CRC cells. As a result, the targeted phytochemical study of A. boeticus enabled the isolation of three new cycloartane glycosides, 6-O-acetyl-3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (1), 3-O-(4-O-malonyl)?d-xylopyranosylcycloastragenol (2), 6-O-acetyl-25-O?d-glucopyranosyl- 3-O?d-xylopyranosylcycloastragenol (3) along with two known compounds, 6-O-acetyl-3-O?d-xylopyranosylcycloastragenol (4) and 3-O?d-xylopyranosylcycloastragenol (5). Importantly, this work demonstrated that the acetylated cycloartane glycosides 1 and 4 might preferentially inhibit cell growth in the CRC cell model resistant to epidermal growth factor receptor (EGFR) inhibitors.
dcterms:created: 2019-05-03T08:29:02Z
Last-Modified: 2019-05-03T10:41:13Z
dcterms:modified: 2019-05-03T10:41:13Z
title: Spectroscopic Characterization and Cytotoxicity Assessment towards Human Colon Cancer Cell Lines of Acylated Cycloartane Glycosides from Astragalus boeticus L.
xmpMM:DocumentID: uuid:8ee65b50-8e9e-4e89-96b9-b2e1284c0966
Last-Save-Date: 2019-05-03T10:41:13Z
pdf:docinfo:keywords: Astragalus boeticus L.; spectroscopic analysis; cytotoxic activity; human colon cancer cell lines; acetylated astragalosides; Fabaceae
pdf:docinfo:modified: 2019-05-03T10:41:13Z
meta:save-date: 2019-05-03T10:41:13Z
pdf:docinfo:custom:PTEX.Fullbanner: This is pdfTeX, Version 3.14159265-2.6-1.40.17 (TeX Live 2016/W32TeX) kpathsea version 6.2.2
Content-Type: application/pdf
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Vittoria Graziani, Assunta Esposito, Monica Scognamiglio, Angela Chambery, Rosita Russo, Fortunato Ciardiello, Teresa Troiani, Nicoletta Potenza, Antonio Fiorentino and Brigida D?Abrosca
dc:subject: Astragalus boeticus L.; spectroscopic analysis; cytotoxic activity; human colon cancer cell lines; acetylated astragalosides; Fabaceae
access_permission:assemble_document: true
xmpTPg:NPages: 17
pdf:charsPerPage: 3130
access_permission:extract_content: true
access_permission:can_print: true
pdf:docinfo:trapped: False
meta:keyword: Astragalus boeticus L.; spectroscopic analysis; cytotoxic activity; human colon cancer cell lines; acetylated astragalosides; Fabaceae
access_permission:can_modify: true
pdf:docinfo:created: 2019-05-03T08:29:02Z